Multiple outlets cover AngioDynamics’ Q4 2026 earnings activity. Seeking Alpha previews the company’s Q4 2026 results, indicating what investors are watching ahead of the release, while other coverage centers on the earnings call materials and the actual results. According to Investing.com, AngioDynamics beats Q4 2026 estimates, and the shares rise following the reported quarter and earnings call discussion. Seeking Alpha also publishes the company’s Q4 2026 results and the earnings call presentation, providing additional detail on the quarter’s performance and management’s commentary. Across the sources, the common elements are that AngioDynamics reports Q4 2026 results, holds an earnings call/presentation for investors, and the reported quarter comes in above consensus expectations, which is associated with an increase in the stock price. The combined reporting does not specify all figures in the provided excerpts, but it consistently links the earnings release and call with the quarter’s outperformance versus estimates and subsequent market reaction.